单核细胞趋化蛋白1对肺癌A549细胞迁移和侵袭的影响及其机制

doi:10.13481/j.1671-587X.20240310

摘要/Abstract

摘要：

目的探讨单核细胞趋化蛋白1（MCP-1）对肺癌A549细胞迁移和侵袭的影响，并阐明其作用机制。方法采用免疫组织化学法检测80例非小细胞肺癌（NSCLC）及癌旁正常肺组织中MCP-1蛋白表达情况。体外培养人肺癌A549细胞，MCP-1-小干扰RNA（siRNA）实验分为空白组、阴性对照组（si-NC组）、MCP-1-siRNA-1组和MCP-1-siRNA-2组；MCP-1过表达实验分为对照组、空载对照组（OE-NC组，转染MCP-1过表达空载质粒）、过表达MCP-1组（OE-MCP-1组，转染MCP-1过表达质粒）、过表达MCP-1+细胞外调节蛋白激酶（ERK）信号通路抑制剂PD98059组（OE-MCP-1+PD98059组，共转染MCP-1过表达质粒和PD98059）和PD98059组（转染PD98059）。分别将MCP-1-siRNA和质粒转染至肺癌A549细胞，Western blotting法验证各组A549细胞转染效率。细胞划痕实验和Transwell小室实验观察各组A549细胞迁移率和侵袭细胞数，Western blotting法检测各组A549细胞中磷酸化ERK（p-ERK）、总ERK（t-ERK）和上皮-间质转化（EMT）相关蛋白表达水平。结果与癌旁组织比较，NSCLC组织中MCP-1蛋白阳性表达率明显升高（P<0.05）；NSCLC组织中MCP-1蛋白表达水平与TNM分期和淋巴结转移有关联（P<0.05）。与si-NC组比较，MCP-1-siRNA-1组和MCP-1-siRNA-2组A549细胞中MCP-1蛋白表达水平均明显降低（P<0.01）；与对照组和OE-NC组比较，OE-MCP-1组A549细胞中MCP-1蛋白表达水平明显升高（P<0.01）。细胞划痕实验，与si-NC组比较，MCP-1-siRNA-1组和MCP-1-siRNA-2组细胞迁移率均明显降低（P<0.01）；与 OE-NC 组比较，OE-MCP-1 组细胞迁移率明显升高（P<0.01）；与 OE-MCP-1 组比较，OE-MCP-1+PD98059 组细胞迁移率明显降低（P<0.01）；与 OE-MCP-1+PD98059 组比较，PD98059组细胞迁移率明显降低（P<0.01）。Transwell小室实验，与si-NC组比较，MCP-1-siRNA-1组和MCP-1-siRNA-2组侵袭细胞数明显减少（P<0.01）；与OE-NC组比较，OE-MCP-1组侵袭细胞数明显增加（P<0.01）；与OE-MCP-1组比较， OE-MCP-1+PD98059组侵袭细胞数明显减少（P<0.01）；与 OE-MCP-1+PD98059 组比较，PD98059 组侵袭细胞数明显减少（P<0.01）。 Western blotting 法，与si-NC组比较，MCP-1-siRNA-1组和MCP-1-siRNA-2组A549细胞中p-ERK、波形蛋白（Vimentin）和N-钙黏蛋白（N-cadherin）表达水平均明显降低（P<0.05或P<0.01），E-钙黏蛋白（E-cadherin）表达水平均明显升高（P<0.01）；与 OE-NC 组比较， OE-MCP-1 组 A549 细胞中p-ERK、Vimentin和N-cadherin蛋白表达水平均明显升高（P<0.01），E-cadherin蛋白表达水平均明显降低（P<0.01）；与OE-MCP-1组比较，OE-MCP-1+PD98059组A549细胞中p-ERK、Vimentin和N-cadherin蛋白表达水平均明显降低（P<0.01），E-cadherin蛋白表达水平均明显升高（P<0.05）；与OE-MCP-1+PD98059组比较，PD98059组A549细胞中p-ERK、Vimentin和N-cadherin蛋白表达水平均明显降低（P<0.05 或 P<0.01）， E-cadherin蛋白表达水平明显升高（P<0.01）。结论 MCP-1蛋白可上调肺癌A549细胞中EMT相关蛋白表达，促进肺癌A549细胞的迁移和侵袭，其作用机制与激活ERK信号通路有关。

关键词: 单核细胞趋化蛋白1, 细胞外信号调节激酶, 癌，非小细胞肺, 细胞侵袭, 细胞迁移

Abstract:

Objective To discuss the effects of monocyte chemoattractant protein-1 （MCP-1） on the migration and invasion of lung cancer A549 cells， and to clarify the mechanisms. Methods Immunohistochemistry method was used to detect the expression of MCP-1 protein in 80 cases of non-small cell lung cancer （NSCLC） and adjacent normal lung tissues. The human lung cancer A549 cells were cultured in vitro. The MCP-1-small interfering RNA （siRNA） experiment was divided into blank group， negative control group （si-NC group）， MCP-1-siRNA-1 group， and MCP-1-siRNA-2 group. The MCP-1 over-expression experiment was divided into control group， empty vector control group （OE-NC， transfected with MCP-1 over-expression empty vector）， over-expression MCP-1 group （OE-MCP-1 group， transfected with MCP-1 over-expression plasmid）， over-expression MCP-1+extracellular regulated protein kinase （ERK） pathway inhibitor PD98059 group （OE-MCP-1+PD98059 group， co-transfected with MCP-1 over-expression plasmid and PD98059）， and PD98059 group （transfected with PD98059）.The MCP-1 siRNA and plasmids were transfected into the lung cancer A549 cells； Western blotting method was used to verify the transfection efficiencies of the cells in various groups； the migration rate and the number of invasion cells in various groups were observed by wound healing assay and Transwell chamber assay， respectively； Western blotting method was also used to detect the expression levels of phosphorylated ERK （p-ERK）， total ERK （t-ERK）， and epithelial-mesenchymal transition （EMT）-related proteins in the A549 cells in various groups. Results Compared with adjacent tissue， the positive expression rate of MCP-1 protein in NSCLC tissue was significantly increased （P<0.05）， and the expression level of MCP-1 protein was related to TNM stage and lymph node metastasis （P<0.05）. Compared with si-NC group， the expression level of MCP-1 protein in the cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups was significantly decreased （P<0.01）. Compared with control group and OE-NC group， the expression level of MCP-1 protein in the cells in OE-MCP-1 group was significantly increased （P<0.01）. The wound healing assay results showed that compared with si-NC group， the migration rate of the cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups were significantly decreased （P<0.01）. Compared with OE-NC group， the migration rate of the cells in OE-MCP-1 group was significantly increased （P<0.01）； compared with OE-MCP-1 group， the migration rate of the cells in OE-MCP-1+PD98059 group was significantly decreased （P<0.01）. Compared with OE-MCP-1+PD98059 group， the migration rate of the cells in PD98059 group was significantly decreased （P<0.01）. The Transwell chamber assay results showed that compared with si-NC group， the number of invasion cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups was significantly decreased （P<0.01）. Compared with OE-NC group， the number of invasion cells in OE-MCP-1 group was significantly increased （P<0.01）； compared with OE-MCP-1 group， the number of invasion cells in OE-MCP-1+PD98059 group was significantly decreased （P<0.01）； compared with OE-MCP-1+PD98059 group， the number of invasion cells in PD98059 group was significantly decreased （P<0.01）.The Western blotting results showed that compared with si-NC group， the expression levels of p-ERK， Vimentin， and N-cadherin protein in the cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups were significantly decreased （P<0.05 or P<0.01）， and the expression level of E-cadherin proteins was significantly increased （P<0.01）. Compared with OE-NC group， the expression levels of p-ERK， Vimentin， and N-cadherin proteins in the cells in OE-MCP-1 group were significantly increased （P<0.01）， and the expression level of E-cadherin protein was significantly decreased （P<0.01）. Compared with OE-MCP-1 group， the expression levels of p-ERK， Vimentin， and N-cadherins proteins in the OE-MCP-1+PD98059 group were significantly decreased （P<0.01）， and the expression level of E-cadherin protein was significantly increased （P<0.05）. Compared with OE-MCP-1+PD98059 group， the expression levels of p-ERK， Vimentin， and N-cadherin proteins in the cells in PD98059 group were significantly decreased （P<0.05 or P<0.01）， and the expression level of E-cadherin protein was increased （P<0.01）. Conclusion MCP-1 protein can upregulate the expression of EMT-related proteins in the lung cancer A549 cells， and promote the migration and invasion of the lung cancer A549 cells； its mechanism may be related to the activation of the ERK signaling pathway.

Key words: Monocyte chemoattractant protein-1, Extracellular-signal regulated protein kinase, Cancer，non-small cell lung, Cell invasion, Cell migration

中图分类号:

R734.2

王远,王志娟,张明姝,王艺慧,张晴,叶丽平. 单核细胞趋化蛋白1对肺癌A549细胞迁移和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2024, 50(3): 666-675.

Yuan WANG,Zhijuan WANG,Mingshu ZHANG,Yihui WANG,Qing ZHANG,Liping YE. Effects of monocyte chemoattractant protein-1 on invasion and migration of lung cancer A549 and their mechanisms[J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 666-675.

图/表 9

图1

表1

图2

图3

图4

图5

图6

图7

图8

参考文献 20

1	SUNG H， FERLAY J， SIEGEL R L， et al. Global cancer statistics 2020： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin， 2021， 71（3）： 209-249.
2	DE LA FUENTE LÓPEZ M， LANDSKRON G， PARADA D， et al. The relationship between chemokines CCL2， CCL3， and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer［J］. Tumour Biol， 2018， 40（11）： 1010428318810059.
3	FANG W B， JOKAR I， ZOU A， et al. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase （MAPK）-dependent mechanisms［J］. J Biol Chem， 2012， 287（43）： 36593-36608.
4	LIU W， WANG L， ZHANG J J， et al. Purification of recombinant human chemokine CCL2 in E. coli and its function in ovarian cancer［J］. 3 Biotech， 2021， 11（1）： 8.
5	THOMAS M U， MESSEX J K， DANG T， et al. Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK［J］. FEBS J， 2021， 288（6）： 1871-1886.
6	MITTAL P， WANG L Q， AKIMOVA T， et al. The CCR2/MCP-1 chemokine pathway and lung adenocarcinoma［J］. Cancers， 2020， 12（12）： 3723.
7	ALTORKI N K， MARKOWITZ G J， GAO D C， et al. The lung microenvironment： an important regulator of tumour growth and metastasis［J］. Nat Rev Cancer， 2019， 19（1）： 9-31.
8	PAUSCH T M， AUE E， WIRSIK N M， et al. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes［J］. Sci Rep， 2020， 10（1）： 5420.
9	FENG L， QI Q， WANG P， et al. Serum level of CCL2 predicts outcome of patients with pancreatic cancer［J］. Acta Gastroenterol Belg， 2020， 83（2）： 295-299.
10	LI Y L， SHI Z H， WANG X， et al. Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma［J］. Ann Hematol， 2019， 98（2）： 413-422.
11	HEISKALA M， LEIDENIUS M， JOENSUU K， et al. High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer［J］. Virchows Arch， 2019， 474（1）： 3-12.
12	LI L， LIU Y D， ZHAN Y T， et al. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma［J］. Thorac Cancer， 2018， 9（7）： 775-784.
13	MANFIOLETTI G， FEDELE M. Epithelial-mesenchymal transition （EMT） 2021［J］. Int J Mol Sci， 2022， 23（10）： 5848.
14	HUANG Y H， HONG W Q， WEI X W. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis［J］. J Hematol Oncol， 2022， 15（1）： 129.
15	DONG Y Q， ZHANG S N， ZHAO S Y， et al. CCL2 promotes lymphatic metastasis via activating RhoA and Rac1 pathway and predict prognosis to some extent in tongue cancer［J］. Cancer Biol Ther， 2023， 24（1）：2205342.
16	LING Z H， YANG X， CHEN X B， et al. CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma［J］. J Oral Pathol Med， 2019， 48（6）： 477-482.
17	CHEN X Z， YANG M Q， YIN J， et al. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling［J］. Cell Commun Signal， 2022， 20（1）： 92.
18	ROBLEK M， PROTSYUK D， BECKER P F， et al. CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis［J］. Mol Cancer Res， 2019， 17（3）： 783-793.
19	YAN J， GAO Y P， LIN S， et al. EGR1-CCL2 feedback loop maintains epithelial-mesenchymal transition of cisplatin-resistant gastric cancer cells and promotes tumor angiogenesis［J］. Dig Dis Sci， 2022， 67（8）： 3702-3713.
20	ZHONG Y Z， LIN Z C， LU J H， et al. CCL2-CCL5/CCR4 contributed to radiation-induced epithelial-mesenchymal transition of HPAEpiC cells via the ERK signaling pathways［J］. Am J Transl Res， 2019， 11（2）： 733-743.

Clinicopathological characteristic	n	MCP-1
Clinicopathological characteristic	n	-	+	χ²	P
Gender
Male	34	15	19	1.105	0.293
Female	46	15	31	1.105	0.293
Age
≤60	20	8	12	0.071	0.790
>60	60	22	38	0.071	0.790
Maximum diameter of tumor（cm）
≤3	53	21	32	0.302	0.583
>3	27	9	18	0.302	0.583
Histological type
Squamous cell carcinoma	21	5	16	2.277	0.131
Adenocarcinoma	59	25	34	2.277	0.131
Differentiation
Well-moderate	53	21	32	0.302	0.583
Poor	27	9	18	0.302	0.583
TNM stage
Ⅰ	52	24	28	4.747	0.029
Ⅱ+Ⅲ	28	6	22	4.747	0.029
Lymph node metastasis
Yes	26	5	21	5.485	0.019
No	54	25	29	5.485	0.019

[1]	陈宗军,陈亚红,黄丽云,梁紫盈. 非小细胞肺癌A549细胞基因组不稳定性和MYC基因突变在吉西他滨耐药中的作用[J]. 吉林大学学报(医学版), 2024, 50(2): 355-363.
[2]	陈爽,李红. 沉默FOXK1基因对胃癌HGC-27细胞增殖、迁移和侵袭的影响[J]. 吉林大学学报(医学版), 2024, 50(2): 371-378.
[3]	魏雁虹,杨晨雪,杨广民,宋帅,李明,杨海娇,魏海峰. 下调HMGB2表达对肝癌LM3细胞上皮-间质转化的抑制作用及其AKT/mTOR信号通路机制[J]. 吉林大学学报(医学版), 2024, 50(1): 143-149.
[4]	曾洁,俞雪燕,罗婷,徐江. PD-L1对人口腔鳞状细胞癌细胞增殖、迁移和侵袭的影响[J]. 吉林大学学报(医学版), 2024, 50(1): 18-24.
[5]	周佳,邱智东,林喆,律广富,许佳明,林贺,王可欣,王雨辰,黄晓巍. 白屈菜红碱对人卵巢癌SKOV3细胞迁移、侵袭和上皮-间质转化的影响[J]. 吉林大学学报(医学版), 2024, 50(1): 25-32.
[6]	孙玉学,刘自强,吴豪,赵黎明,高涛,黄海燕,栗超跃. 小檗碱对人胶质瘤T98G细胞迁移和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2024, 50(1): 50-57.
[7]	任爱华,鞠欣达,柳骜飞,刘永超,刘岩峰. 灵芝酸A对人非小细胞肺癌PC-9细胞增殖和凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2023, 49(6): 1466-1472.
[8]	欧曼颖,胡春霞,李跃萍. 子痫前期患者胎盘组织中抑微管装配蛋白1表达对滋养层细胞的影响及其机制[J]. 吉林大学学报(医学版), 2023, 49(6): 1519-1527.
[9]	王丹丹,周宁,刘冬芹,赵杰,梁超,代娟娟,武艳. MiR-491-5p过表达对人鼻咽癌HONE-1细胞增殖和迁移的影响[J]. 吉林大学学报(医学版), 2023, 49(5): 1134-1139.
[10]	盖晓东,赵颖,王鹤霏,何程远,王星翔,历春. FOXP3调控非小细胞肺癌A549细胞对阿霉素敏感性的作用及其机制[J]. 吉林大学学报(医学版), 2023, 49(5): 1161-1167.
[11]	董勇,徐菱遥,华静,梁晗,刘东亚,赵俊波,孙正路,程序,魏书堂. 巨噬细胞外泌体lncRNA HULC对肝癌细胞迁移、侵袭和转移的影响及其机制[J]. 吉林大学学报(医学版), 2023, 49(5): 1217-1226.
[12]	赵月生,李祖彬,刘海鸥,陶昆麟,赵齐海,李娜. 沉默CDKL1基因通过调控PTEN/Akt/mTOR信号通路对乳腺癌MCF-7细胞增殖和侵袭的抑制作用[J]. 吉林大学学报(医学版), 2023, 49(5): 1234-1242.
[13]	靳莉,张小红,胡朝阳,李凤芝,崔永亮,李杨,刘倩倩,乔艳俊. 槲皮素对人肺癌A549细胞移植瘤模型小鼠移植瘤生长和肺转移及细胞侵袭和迁移的影响及其机制[J]. 吉林大学学报(医学版), 2023, 49(4): 1018-1026.
[14]	王旭颖,荆明箴,余谨,付荣,杨茹. miR-181a-5p和BACH2表达对白血病CCRF-CEM细胞凋亡和侵袭的影响[J]. 吉林大学学报(医学版), 2023, 49(4): 840-849.
[15]	张湘豫,胡溢洪,韩语诚,邹先琼. 1-磷酸神经酰胺转运蛋白对人口腔鳞状细胞癌HSC-3细胞生物学行为的影响[J]. 吉林大学学报(医学版), 2023, 49(4): 875-883.